New insights in prolactin: pathological implications.
Le Kremlin-Bicêtre, France. In Nat Rev Endocrinol, 17 Apr 2015
The major isoform, 23 kDa prolactin, acts via its membrane receptor, the prolactin receptor (PRL-R), which is a member of the haematopoietic cytokine superfamily and for which the mechanism of activation has been deciphered.
Outcomes of Endoscopic Transsphenoidal Pituitary Surgery.
Charlottesville, United States. In Endocrinol Metab Clin North Am, 31 Mar 2015
This article discusses some of the recent studies reporting outcomes from endoscopic series for Cushing disease, acromegaly, prolactin-secreting tumors, and nonfunctioning macroadenomas.
São Paulo, Brazil. In Endocrinol Metab Clin North Am, 31 Mar 2015
Dopamine agonists are efficacious in about 80% to 90% of patients with prolactinoma, leading to reduction of serum prolactin levels and tumor dimensions.
Bisphenol A and phthalate endocrine disruption of parental and social behaviors.
Columbia, United States. In Front Neurosci, Dec 2014
These behavioral disturbances may originate by altering the fetal or adult gonadal production of testosterone or estrogen, expression of ESR1, ESR2, and AR in the brain regions governing these behaviors, neuropeptide/protein hormone (oxytocin, vasopressin, and prolactin) and their cognate neural receptors, and/or through epimutations.
Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer.
More papers using
Boston, United States. In J Clin Oncol, Nov 2014
Therefore, we evaluated whether inclusion of plasma estradiol, estrone, estrone sulfate, testosterone, dehydroepiandrosterone sulfate, prolactin, and sex hormone-binding globulin (SHBG) improved risk prediction for postmenopausal invasive breast cancer (n = 437 patient cases and n = 775 controls not using postmenopausal hormones) in the Nurses' Health Study.